Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

Quebecers * reductase 161

- Keyword Abstract -+
among blood donors at Queen Elizabeth Hospital, Malawi/Sero-pr 33206
ptions about HIV/AIDS/ Quick methods to overcome misconceptio 43520
e combination therapy ( QUINTET Trial)/Peripheral neuropathy du 12397
man growth hormone ( r-hGH; Serostim~)/Preservation of restore 32182
human erythropoietin ( r-Hu-EPO ) in children with HIV infection: E 60150
nd immunosuppressed rabbits after intraocular inoculation of hum 11231
corneal endothelium in treated with sub-conjunctival ganci 11237
enicity of pre-exposure rabies immunization in HIV-infected childr 32449
V-related tuberculosis/ Race, age, gender, and risk-group differen 42215
g HIV infected women/, HIV symptoms, recovery from drug 60408
care is associated with race, HIV symptoms and recovery from su 42214
persons living with HIV/ Racial inequalities in the receipt of HIV/AI 44166
re for language/cultural/ racial minorities/Improving access to care 32422
)/Wide pattern of chest radiographic abnormalities in HIV+ patien 60601
HIV infected patients, a radiological evaluation/Active mycobacte 22148
nursing staff) in eastern Rajasthan State of India/A survey of know 33545
te-based prostitution of,India/Impact of HIV interventio 43354
ex work communities in, India/Implementing sexual he 60142
d brothel in Goalanda, Rajbari /Behavioral risk assessment and s 33248
rol during pregnancy in Rakai, Uganda: Impact on maternal and inf 528*/23276
ed with STD symptoms, community-based study, Uganda/P 524*/23372
wanza, Masaka and?/The future of randomised control tr 24176
seroprevalence in rural District, Uganda: Results from a pop 60932
s of the C-C chemokine RANTES with enhanced HIV-suppressive 11101
n/MIP-la, MIP-1/ and /-chemokines increase the repli 11119
nd CCR5, CCR1, IFNy, expression in lymphoid tissues/ 11222
rogression/sCD30 and are potential correlates of HIV dis 21183
IL-2, IFNy, TNFa, and, using whole blood are equivalen 21184
/New anti-HIV function: activity via CCR3 is required for s 31148
minooxypentane (AOP)- as inhibitor of HIV-1 infectivity wit 59*/41231
se progression/Serum as an early prognostic marker of 43101
d diseases in victims of rape the experience at St. Gabriel's hospit 60803
n immunosuppressed rats during acute PCP/Extrapulmonary dis 31220
uctive and child health ( RCH - RTI/STD/HIV/AIDS) package that f 13575
Club des Amis" (CDA), RCI /HIV positives commitment in preventi 43323
combat HIV and AIDS ( RCMA )/The main goals of Russian Civil-M 34346
atic Republic of Congo ( RDC )/HIV/AIDS case management: Whic 34178
to achieve avoiding the re-infection in people living with HIV/AIDS 14327
n HIV patients with TB/ Re-introducing anti-tuberculosis (TB) me 32267
ultiple wash, dry and re-lubrication cycles/Female condom re- 33124
sal rates for serological re-testing among drug users in opiate sub 43135
ability/Syringe source, re-use and discard among IDUs in a city wi 23200
ycles/Female condom: Assessing structural integrity after 33124
scent Care and Health ( REACH) project/Human papillomavirus (H 13283
jection drug users (the I study)/Gender differences in the 23168
jection drug users (the I study)/Needle exchange use an 23191
V infection?/Could the model be the panacea to female g 23384
munity Health Study ( II)/Changing patterns in injection 33394
eme/HIV adverse drug reaction (ADR) reporting scheme/HIV adv 12385
on by polymerase chain (PCR) in Taiwan/Rapid detection 13146
s/Severe inflammatory (SIR) after starting HAART in AID 22130
nd polymerase chain for detection of microsporidia in cl 22230

Keyword

Abstract

a-analysis/Chemokine genotypes and HIV disease prog 13311
ndividuals/Chemokine CCR2b 641 polymorphism and its 13327
ength analysis of T cell (TCR) Vp repertoire/Distinctive p 212*/21106
epertoire of chemokine expression in the female genital t 335*/21109
ation of CC chemokine 5 and focal adhesion kinase in C 55*/21135
s with the CD4/CXCR4 complex/Signal transduction du 21140
ctic cytokines and their expression in adult Simian astroc 21144
ses and CC-chemokine 5 (CCR5) genotype in long-term 31114
nfection on chemokine expression in CD4+ tetanus toxoi 31141
arkers and chemokine 5 (CCR5) genotype in highly exp 31147
okines and chemokine on HIV rgpl20-induced B lympho 31159
unction/Interleukin-8 down-regulation on polymorphon 31167
ntagonist of the CXCR4 /Anti-HIV activity of AMD3465, a 41183
Chemokine, chemokine, cytokine and monokine levels in 60132
n in the P-chemokines receptors (A32 CCR5) sequency codificat 11123
olvement of chemokine in the induction of interferon by 21172
mokines and chemokine expression during combined ant 22416
ell expressed chimeric with antibody-type specificity for 41233
n barrier endothelial cell by HIV/Modulation of human bl 60794
ction at IMIP's hospital, Recife, Brazil/Tolerance, adverse reaction 12333
of challenge exposure/ Recombinant vaccine-induced protection 548*/21200
y activity/Generation of recombinant analogues of the C-C chemo 11101
quences/Inter-subtype strains of HIV-1 are frequentl 435*/11170
btypes and intersubtype HIV-1/The global spread of 11181
er in Norway/A unique HIV-1, mixing subtypes A an 11196
s ex vivo infected with a canarypox virus/CTL inducti 11243
ntersubtype A, C and D genotypes from perinatally i 13115
V-1 genetic subtype A/B strain causing an explosive I 13190
btype B, and novel A/B /Genetic characterization of 13194
on immunization with a protein expressing the nativ 550*/21194
wing immunization with gp120 SF2/HIV-1 cross-cla 497*/21201
articles expressed by a vaccinia virus system/Antig 21204
and characterization of BCG-vectored vaccine agai 21206
n with a novel HIV-1 V3 multi-epitope polypeptide: T 21215
ed patients receiving a gp160 envelope vaccine: co 31152
nfection/The efficacy of erythropoietin in AIDS patie 32141
diposity with serostim ( human growth hormone] in p 32164
m SHIVMN challenge/A BCG vaccine for HIV-1 prote 33213
The use sub-cutaneous interleukin-2 with antiretrovir 41240
ions/Use of Murex HIV and anti-HIV-2 assays to dist 42121
population/The use of human erythropoietin (r-Hu- 60150
mbination therapy with human growth hormone (rh 60389
ng after treatment with human growth hormone/Inc 60489
usion recipient/Escape recombinants of HIV-1 in a dual-infected t 11183
African HIV-1 reveals 2 and a geographic sub-dust 11186
usion recipient/Escape of HIV-1 in a dually-infecte 11199
V-1 dual infections and are an integral part of the H 13156
els using vaccinia virus expressing human cytome 31199
1 subtypes B and F, B/F and dual infections in Arge 60727
cent infections in India: Recombination and CTL epitope variation 11194
y infected chimpanzee/ events in env of SIVcpz o 60552
ypes A-J: Inter-subtype recombination plays a significant role on 11177
ntified in China/Genetic of HIV-1 strains identified i 429*/11179
viral triple combination/ Reconstitution of lymph node morpholog 22389
ary HIV infection/Rapid reconstitution of the T-cell receptor (TCR 12185
of viremia and immune in seroconverting patients r 12191
ected children/Immune and role of thymus during p 114*/12247
analysis of the immune after HAART (saquinavir-S 21123
se. Role of the immune in therapy for HIV-lympho 22293
en: Kinetics of immune /Combination therapy with 22362
cell dynamics/Immune of HIV discordant monozyg 272*/22411
nt/Successful immune over four years after thymic 22421
Functional lymphocyte and HIV-1 specific T cell re 113*/31134
uadri-96 trial"/Immune in the "Quadri-96 trial"/Im 31172
munologic function and in HIV-infected patients on 338*/31186
viral kinetics and T cell in lymphoid tissues of asy 41228
f HIV from syringes/ Recovery of HIV from syringes/ 23222
al DNA and to immune recovery /Suppression of HIV replication a 12371
AART induced immune vitritis in CMV retinitis patients is i 15*/22240
Jensen medium for the of Mycobacterium tuberculosis fr 41169
ynamics of CD4+ T cell in a large cohort treated with high 41179
ce, HIV symptoms and from substance abuse among HI 42214
/Race, HIV symptoms, from drug abuse, and appointme 60408
First report/Prolonged of visceral Kaposi's sarcoma in t 60510

lymphoid architecture/ Rectal sno-strips and biopsies: A simple m 42147
Nonoxynol-9 enhances rectal infection by herpes simplex virus in 33143
opical microbicides and sex/HIV/STD prevention, topical mi 33159
mple method to assess viral load and lymphoid architecture 42147
in HIV infected women/ Rectovaginal fistula in HIV infected wome 32136
ma using ribonucleotide reductase inhibitors (RRIs) in the murine 12356

tive-polymerase chain
Modifications in the DTH
nked polymerase chain
uction and ligase chain
CSF) polymerase chain
osis using lygase chain
IV-1 polymerase chain
nked polymerase chain
ted polymerase chain

(QC-PCR)/Comparison of the a 624*/22311
in HIV-infected individuals/Modifi 41124
(PCR)/Ultrasensitive HIV detecti 41139
as adjuncts to the diagnosis of sp 41152
(PCR)/Neurological complication 41156
assay (LCR)/Diagnosis of Mycob 41162
does not always correlate with inf 41236
(PCR)/Screening of HIV in 740 B 42134
(PCR) on cerebrospinal fluid (CS 60734

zil/Tolerance, adverse reactions and compliance of children treat
V/AIDS/Psycho-social and coping strategies of patient
m use/Negative partner and sex roles: Influences on mal
HIV testing patterns on to HIV+ diagnosis/The effects o
of Saudi male students' toward a friend with AIDS/An att
bitors therapy/Adverse during protease inhibitors thera
lation/Inactivation and reactivation of integrated HIV-1 genomes
ulatory care center/HIV reactive patients with follow-up in an ambu
f serologically double samples/Discrimination between
ve for assistance of HIV patients/Hospital/day: An alterna
py (HAART)/Skin test reactivity to Mycobacterium avium sensiti
on needs for young and recent-onset drug users outside treatmen
onists of the chemokine receptor CXCR4 and potent inhibitors of H
e/Actin dependent dual HIV-1 infection vs. single recepto
c subtypes/Chemokine usage of HIV-1 primary isolates o
n in the C-C chemokine 5 (CCR5) gene in an HIV-1-infect
terozygous chemokine 5 mutation on response to antiret
ole of CCR5 chemokine gene in vertical HIV-1 transmissi
onstitution of the T-cell (TCR) repertoire following antiret

12333
12455
14151
24266
60104
60658
11127
13105
41160
42468
22171
23232
57*/11107
11120
9*/11166
12105
12116
12162
12185